Endometriosis Pipeline and Clinical Trials Assessment: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Cipla Limited, Teva Pharmaceutical Industries Lt, Zydus Healthcare Limited, Bayer AG, Lannett, Pfizer Inc., Sun Pharma

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Endometriosis pipeline constitutes 18+ key companies continuously working towards developing 25+ Endometriosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Endometriosis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Endometriosis Market.

The Endometriosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Endometriosis Pipeline Report: https://www.delveinsight.com/sample-request/endometriosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Endometriosis treatment therapies with a considerable amount of success over the years.
• Endometriosis companies working in the treatment market are Antev, Mitsubishi Tanabe Pharma America Inc., Hope Medicine (Nanjing) Co., Ltd, Organon, ObsEva, and others, are developing therapies for the Endometriosis treatment
• Emerging Endometriosis therapies in the different phases of clinical trials are- Teverelix-TFA, MT-2990, HMI-115, OG-6219, Linzagolix, and others are expected to have a significant impact on the Endometriosis market in the coming years.
• In February 2022, ObsEva SA has revealed a strategic licensing agreement with Theramex aimed at facilitating the global commercialization and market launch of linzagolix, excluding the United States, Canada, and Asia. Linzagolix is undergoing development as a potential remedy for endometriosis-associated pain, with ObsEva having recently disclosed favorable topline results from its initial Phase 3 trial, EDELWEISS 3, for this specific indication.
• In January 2022, ObsEva SA has reported encouraging topline findings from the Phase 3 EDELWEISS 3 trial involving linzagolix, an oral GnRH antagonist. The trial focused on women experiencing moderate-to-severe pain associated with endometriosis (EAP).


Endometriosis Overview
Endometriosis is a medical condition in which tissue similar to the lining of the uterus, called endometrium, grows outside the uterus. This misplaced tissue can be found on the ovaries, fallopian tubes, outer surface of the uterus, the pelvic cavity, and, in rare cases, other organs in the abdominal cavity.

Get a Free Sample PDF Report to know more about Endometriosis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/endometriosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Endometriosis Drugs Under Different Phases of Clinical Development Include:
• Teverelix-TFA: Antev
• MT-2990: Mitsubishi Tanabe Pharma America Inc.
• HMI-115: Hope Medicine (Nanjing) Co., Ltd
• OG-6219: Organon
• Linzagolix: ObsEva

Endometriosis Route of Administration
Endometriosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Endometriosis Molecule Type
Endometriosis Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Endometriosis Pipeline Therapeutics Assessment
• Endometriosis Assessment by Product Type
• Endometriosis By Stage and Product Type
• Endometriosis Assessment by Route of Administration
• Endometriosis By Stage and Route of Administration
• Endometriosis Assessment by Molecule Type
• Endometriosis by Stage and Molecule Type

DelveInsight's Endometriosis Report covers around 25+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Endometriosis product details are provided in the report. Download the Endometriosis pipeline report to learn more about the emerging Endometriosis therapies at:
https://www.delveinsight.com/sample-request/endometriosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Endometriosis Therapeutics Market include:
Key companies developing therapies for Endometriosis are - Cipla Limited, Teva Pharmaceutical Industries Lt, Zydus Healthcare Limited, Bayer AG, Lannett, Pfizer Inc., Sun Pharmaceutical Industries Limited, TerSera Therapeutics USA, Tolmar Pharmaceuticals, Inc., AbbVie Inc., Sandoz AG, and others.

Endometriosis Pipeline Analysis:
The Endometriosis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Endometriosis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Endometriosis Treatment.
• Endometriosis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Endometriosis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Endometriosis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Endometriosis drugs and therapies-
https://www.delveinsight.com/sample-request/endometriosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Endometriosis Pipeline Market Drivers
• Increasing Prevalence of Endometriosis, increase in research and developmental activities are some of the important factors that are fueling the Endometriosis Market.

Endometriosis Pipeline Market Barriers
• However, lack of diagnosis of the disease, lack of knowledge about the exact cause of the disease and other factors are creating obstacles in the Endometriosis Market growth.

Scope of Endometriosis Pipeline Drug Insight
• Coverage: Global
• Key Endometriosis Companies: Antev, Mitsubishi Tanabe Pharma America Inc., Hope Medicine (Nanjing) Co., Ltd, Organon, ObsEva, and others
• Key Endometriosis Therapies: Teverelix-TFA, MT-2990, HMI-115, OG-6219, Linzagolix, and others
• Endometriosis Therapeutic Assessment: Endometriosis current marketed and Endometriosis emerging therapies
• Endometriosis Market Dynamics: Endometriosis market drivers and Endometriosis market barriers

Request for Sample PDF Report for Endometriosis Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/endometriosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Endometriosis Report Introduction
2. Endometriosis Executive Summary
3. Endometriosis Overview
4. Endometriosis- Analytical Perspective In-depth Commercial Assessment
5. Endometriosis Pipeline Therapeutics
6. Endometriosis Late Stage Products (Phase II/III)
7. Endometriosis Mid Stage Products (Phase II)
8. Endometriosis Early Stage Products (Phase I)
9. Endometriosis Preclinical Stage Products
10. Endometriosis Therapeutics Assessment
11. Endometriosis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Endometriosis Key Companies
14. Endometriosis Key Products
15. Endometriosis Unmet Needs
16 . Endometriosis Market Drivers and Barriers
17. Endometriosis Future Perspectives and Conclusion
18. Endometriosis Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Endometriosis Market https://www.delveinsight.com/report-store/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Endometriosis Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Endometriosis Epidemiology https://www.delveinsight.com/report-store/endometriosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Endometriosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

304 S. Jones Blvd #2432, Las Vegas NVContact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.